[1] Bernier I, Jolles P. Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain [J]. Biochim Biophys Acta, 1984,790: 174-181.
[2] Lamiman K, Keller J M, Mizokami A, et al. Survey of Raf kinase inhibitor protein (RKIP) in multiple cancer types [J].Crit Rev Oncog,2014,19(6): 455-468.
[3] Yesilkanal A E, Rosner M R. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer [J]. Crit Rev Oncog, 2014, 19(6): 447-454.
[4] Fu Z, Smith P C, Zhang L, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis [J]. J Natl Cancer Inst, 2003, 95: 878-889.
[5] Al-Mulla F, Marafie M, Zea Tan T, et al. Raf kinase inhibitory protein role in the molecular subtyping of breast cancer [J]. J Cell Biochem, 2014, 115(3):488-497.
[6] Sun M, Gomes S, Chen P, et al. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2 [J]. Oncogene, 2014,33(27):3528-3537.
[7] Liu H, Li P, Li B, et al. RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224 [J]. Tumour Biol, 2014, 35(10): 10095-10103.
[8] Nisimova L, Wen S, Cross Knorr S, et al. Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer [J]. Crit Rev Oncog, 2014, 19(6): 469-481.
[9] Poma P, Labbozzetta M, Vivona N, et al. Analysis of possible mechanisms accounting for raf-1 kinase inhibitor protein downregulation in hepatocellular carcinoma [J]. OMICS, 2012, 16(11): 579-588.
[10] Koelzer V H, Karamitopoulou E, Dawson H, et al. Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer [J]. Br J Cancer, 2013, 108(10): 2088-2096.
[11] Schmitt J, Noble A, Otsuka M, et al. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6 [J]. Br J Cancer, 2014, 111(8): 1646-1656.
[12] Hill B, De Melo J, Yan J, et al. Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma [J]. Oncotarget, 2014, 5(17): 7406-7419.
[13] Chen Z, Cheng Q, Ma Z, et al. Overexpression of RKIP inhibits cell invasion in glioma cell lines through upregulation of miR-98 [J]. Biomed Res Int, 2013: 685179.
[14] Li J, Wang Y, Song Y, et al. miR-27a regulates cisplatin resistance and metastasis by targeting RKIP in human lung adenocarcinoma cells [J]. Mol Cancer, 2014, 13: 193.
[15] Wang Q, Wu X, Wu T, et al. Clinical significance of RKIP micro-RNA expression in non-small cell lung cancer [J]. Tumour Biol, 2014, 35(5): 4377-4380.
[16] Zhao D, Ma J, Shi J, et al. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression [J]. Oncol Rep, 2013, 30(1): 304-312.
[17] Yu M, Wang Q, Ding J W, et al. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis [J]. Cancer Biomark, 2014, 14(5): 389-400.
[18] Mao W M, Zheng W H, Ling Z Q. Epidemiologic risk factors for esophageal cancer development [J]. Asian Pac J Cancer Prev, 2011, 12(10): 2461-2466.
[19] Banfield M J, Barker J J, Perry A C, et al. Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction [J]. Structure, 1998, 6(10): 1245-1254.
[20] Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinaseactivity and MAP kinase signalling by RKIP [J]. Nature, 1999, 401(6749): 173-177.
[21] Hori N, Chae K S, Murakawa K, et al. A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding protein [J]. Gene, 1994, 140(2): 293-294.
[22] Vallée B S, Coadou G, Labbé H, et al. Peptides corresponding to the N- and C-terminal parts of PEBP are well-structured in solution: new insights into their possible interaction with partners in vivo [J]. J Pept Res, 2003, 61(2):47-57.
[23] Li F F,Song S J,Zhang R N. Phosphatidylethanolaminebinding protein (PEBP) in basic and clinical study [J]. Sheng Li Ke Xue Jin Zhan, 2009, 40(3):214-218.
[24] Vandamme D, Herrero A, Al-Mulla F, et al. Regulation of the MAPK pathway by raf kinase inhibitory protein [J]. Crit Rev Oncog,2014,19(6):405-415.
[25] Yeung K, Janosch P, McFerran B, et al. Mechanismof suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein [J]. Mol Cell Biol, 2000, 20 (9): 3079-3085.
[26] Sisto M,Lisi S,D’Amore M, et al. Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-kappaB in Sjogren syndrome [J]. Immunology,2014, 143(1):42-51.
[27] Fu X, Koller S, Abd Alla J, et al. Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated proteinkinase (MAPK) pathway [J]. J Biol Chem, 2013, 288(11):7738-7755.
[28] Sangiao A S,Manfredi L M,Ruiz P F, et al. Changes in hypothalamic expression of the Lin28/let-7 system and related microRNAs during postnatal maturation and after experimental manipulations of puberty [J]. Endocrinology,2013, 154(2):942-955.
[29] Beshir A B,Ren G,Magpusao A N, et al. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression [J]. Cancer Lett,2010, 299(2):137-149.
[30] Li D X,Cai H Y,Wang X, et al. Promoter methylation of Raf kinase inhibitory protein: a significant prognostic indicator for patients with gastric adenocarcinoma [J]. Exp Ther Med,2014, 8(3):844-850.
[31] Kim H S, Won K Y, Kim G Y, et al. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis [J]. Pathol Res Pract, 2012, 208(5):292-299.
[32] Gao C, Pang L, Ren C,et al. Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma [J]. Pathol Oncol Res, 2012, 18(2):471-477.
[33] Guo W,Dong Z,Lin X,et al. Decreased expression and aberrant methylation of Raf kinase inhibitory protein gene in esophageal squamous cell carcinoma [J]. Cancer Invest,2012, 30(10):703-711.
[34] 魏 红,张向阳,魏东敏,等. 食管鳞状细胞癌Raf 激酶抑制蛋白基因甲基化及micro-RNA表达[J]. 现代中西医结合杂志,2012,21(3):3311-3316.
[35] 魏 红,张向阳,魏东敏,等. 食管鳞状细胞癌组织Raf激酶抑制蛋白和NF-κBp65表达及临床意义[J].现代中西医结合杂志,2012,21(24):2623-2625.
[36] Birner P, Jesch B, Schultheis A,et al. RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases [J]. Clin Exp Metastasis, 2012, 29(6):551-559.